Back to Search
LAUREN ABREY, MD
MD
Neurology Physician
NPI: 1336110360Individual
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
199693(NY)
Research & Publications (20)
Gross total resection of low-grade glioma in adults.
PMID 19348705·Curr Neurol Neurosci Rep·2009
3-trial
Survey of treatment recommendations for anaplastic oligodendroglioma.
PMID 17435180·Neuro Oncol·2007
8-other
High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: long-term follow-up.
PMID 16524945·Neuro Oncol·2006
3-trial
Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model.
PMID 17116938·J Clin Oncol·2006
8-other
Identifying and addressing barriers to the delivery of optimal therapy for primary central nervous system lymphoma in the broader community.
PMID 17169791·Leuk Lymphoma·2006
6-review
Does trastuzumab increase the risk of isolated CNS metastases in patients with breast cancer?
PMID 16932571·Nat Clin Pract Neurol·2006
8-other
Concomitant chemoradiotherapy followed by adjuvant temozolomide improves survival in glioblastoma multiforme.
PMID 15865881·Curr Neurol Neurosci Rep·2005
3-trial
Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma.
PMID 15955902·J Clin Oncol·2005
8-other
Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis.
PMID 14615443·J Clin Oncol·2003
8-other
High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma.
PMID 14686732·J Neurooncol·2003
3-trial
Treatment of brain metastases: a short review of current therapies and the emerging role of temozolomide.
PMID 16224412·Clin Adv Hematol Oncol·2003
6-review
A phase II trial of temozolomide for patients with recurrent or progressive brain metastases.
PMID 11718258·J Neurooncol·2001
3-trial
Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma.
PMID 19562255·J Neurooncol·2010
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1275 YORK AVE
NEW YORK, NY 10021 - Phone
- (646) 227-3813
Quick Facts
- NPI
- 1336110360
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile